Literature DB >> 13715852

The enzymic dephosphorylation and oxidation of psilocybin and psilocin by mammalian tissue homogenates.

A HORITA, L J WEBER.   

Abstract

Entities:  

Keywords:  INDOLES/metabolism; PHOSPHORYLASES/metabolism

Mesh：

Substances：

Year:  1961        PMID： 13715852     DOI： 10.1016/0006-2952(61)90124-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  15 in total

1.  Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice.

Authors:  C Castellano
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Comparison of psilocin with psilocybin, mescaline and LSD-25.

Authors:  A B WOLBACH; E J MINER; H ISBELL
Journal:  Psychopharmacologia       Date:  1962

3.  A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2011-12-03       Impact factor: 2.686

4.  Development of a psilocin immunoassay for serum and blood samples.

Authors:  C Albers; H Köhler; M Lehr; B Brinkmann; J Beike
Journal:  Int J Legal Med       Date:  2004-08-03       Impact factor: 2.686

5.  Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Angela Gasse; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2012-11-27       Impact factor: 2.686

Review 6.  Licit and illicit drug use in cluster headache.

Authors:  Amelie Govare; Elizabeth Leroux
Journal:  Curr Pain Headache Rep       Date:  2014-05

7.  High dose psilocybin is associated with positive subjective effects in healthy volunteers.

Authors:  Christopher R Nicholas; Kelsey M Henriquez; Michele C Gassman; Karen M Cooper; Daniel Muller; Scott Hetzel; Randall T Brown; Nicholas V Cozzi; Chantelle Thomas; Paul R Hutson
Journal:  J Psychopharmacol       Date:  2018-06-27       Impact factor: 4.153

8.  Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.

Authors:  J Koerner; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.

Authors:  Adam L Halberstadt; Liselore Koedood; Susan B Powell; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2010-12-08       Impact factor: 4.153

10.  Novel, unifying mechanism for mescaline in the central nervous system: electrochemistry, catechol redox metabolite, receptor, cell signaling and structure activity relationships.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.